Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023)
Revvity's (RVTY) quarterly Asset Writedowns and Impairment came in at -$3.9 million in Q1 2023, down 148.73% on a QoQ basis from $7.9 million in Q1 2021.
Revvity (RVTY) Asset Writedowns and Impairment (2013 - 2023) Analysis & Trends
Revvity (RVTY) has 3 years of Asset Writedowns and Impairment data on file, last reported at -$3.9 million in Q1 2023.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$3.9 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $4.3 million (changed N/A YoY) and the FY2025 annual result came in at $4.8 million, down 79.03% from the prior year.
- Asset Writedowns and Impairment slipped to -$3.9 million in Q1 2023, from $7.9 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $7.9 million in Q1 2021 to a low of -$3.9 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2023 | -3.87 Mn |
| Jan 1, 2023 | -3.87 Mn |
| Jan 3, 2021 | 7.94 Mn |
| Jan 3, 2021 | 7.94 Mn |
| Dec 29, 2013 | 200,000.00 |
| Dec 29, 2013 | 200,000.00 |